Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$558M |
| 2 |
Apple
AAPL
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$209M |
| 4 |
Amazon
AMZN
|
+$197M |
| 5 |
Visa
V
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$86.3M |
| 2 |
TSMC
TSM
|
+$77.2M |
| 3 |
iShares MBS ETF
MBB
|
+$44.5M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$43.8M |
| 5 |
Vale
VALE
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Healthcare | 10.27% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Fortinet
FTNT
$123B
| $439K | ﹤0.01% |
9,225
-625
| -6% | -$26.7K |
|
652
iShares MSCI Taiwan ETF
EWT
$10.6B
| $436K | ﹤0.01% |
6,824
+878
| +15% | +$54.6K |
|
653
Accenture
ACN
$104B
| $430K | ﹤0.01% |
1,459
+236
| +19% | +$67.6K |
|
654
Smith & Nephew
SNN
$12.8B
| $429K | ﹤0.01% |
9,867
-349
| -3% | -$14.7K |
|
655
Roku
ROKU
$21.9B
| $427K | ﹤0.01% |
+929
| New | +$329K |
|
656
W.P. Carey
WPC
$16.5B
| $427K | ﹤0.01% |
5,840
-172
| -3% | -$12.6K |
|
657
Emerson Electric
EMR
$89B
| $412K | ﹤0.01% |
+4,279
| New | +$402K |
|
658
Exelon
EXC
$47.2B
| $410K | ﹤0.01% |
12,978
-923
| -7% | -$29.7K |
|
659
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
| $409K | ﹤0.01% |
2,686
+730
| +37% | +$108K |
|
660
Xcel Energy
XEL
$48.6B
| $409K | ﹤0.01% |
6,212
-584
| -9% | -$40.7K |
|
|
EGRX
661
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $409K | ﹤0.01% |
9,557
+2,884
| +43% | +$119K |
|
662
Cincinnati Financial
CINF
$27.5B
| $407K | ﹤0.01% |
3,487
-72
| -2% | -$8.31K |
|
663
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
| $406K | ﹤0.01% |
5,002
-1,310
| -21% | -$104K |
|
664
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $402K | ﹤0.01% |
+10,165
| New | +$402K |
|
665
Corning
GLW
$137B
| $401K | ﹤0.01% |
9,793
+53
| +0.5% | +$2.31K |
|
666
iShares New York Muni Bond ETF
NYF
$1.39B
| $401K | ﹤0.01% |
6,863
| – | – |
|
667
Rithm Capital
RITM
$5.72B
| $401K | ﹤0.01% |
+37,850
| New | +$402K |
|
668
iShares MSCI South Korea ETF
EWY
$24.8B
| $399K | ﹤0.01% |
4,286
+1,778
| +71% | +$164K |
|
|
FIEE
669
DELISTED
FI Enhanced Europe 50 ETN
FIEE
| $399K | ﹤0.01% |
2,048
-229
| -10% | -$44K |
|
670
Northrop Grumman
NOC
$78.4B
| $397K | ﹤0.01% |
1,092
-90
| -8% | -$32.4K |
|
671
Illinois Tool Works
ITW
$84.9B
| $391K | ﹤0.01% |
1,748
-696
| -28% | -$159K |
|
672
Automatic Data Processing
ADP
$108B
| $389K | ﹤0.01% |
1,957
+404
| +26% | +$78.5K |
|
673
iShares Biotechnology ETF
IBB
$9.39B
| $386K | ﹤0.01% |
2,357
+101
| +4% | +$15.6K |
|
674
Phillips 66
PSX
$82.5B
| $385K | ﹤0.01% |
4,484
-551
| -11% | -$46.5K |
|
675
Vanguard Real Estate ETF
VNQ
$39.2B
| $380K | ﹤0.01% |
3,733
+814
| +28% | +$80.7K |
|
Similar funds
Ken Fisher's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Fisher held 1,100 positions worth $159B, up 12% from $142B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher deployed $4.92B of net new capital in Q2 2021, opening 101 new positions and adding to 388 existing holdings. Its largest new stake was Organon & Co: 967,460 shares worth $29.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was TSMC, an estimated $77.2M trimmed.
- Ken Fisher's largest Q2 2021 buy was Organon & Co: 967,460 shares worth $29.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2021, an estimated $558M increase.
- Ken Fisher's biggest Q2 2021 reduction was TSMC, cutting an estimated $77.2M.
- Ken Fisher fully exited Coherent Inc in Q2 2021, selling an estimated $86.3M.
- Ken Fisher's ten largest holdings make up 32% of its $159B portfolio in Q2 2021.
- Ken Fisher opened 101 new positions and closed 90 in Q2 2021.
- Ken Fisher's portfolio value rose 12% quarter-over-quarter to $159B.
Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.